Video

Dr. Savvides on the Utility of Immunotherapy in Lung Cancer

Panayiotis S. Savvides, MD, discusses the utility of immunotherapy in lung cancer.

Panayiotis S. Savvides, MD, a medical oncologist at Mayo Clinic Arizona, discusses the utility of immunotherapy in lung cancer.

Documenting the efficacy of immunotherapy in lung cancer has revolutionized what patients have been offered over the past few years, says Savvides. The options that are avaliable to patients have significantly improved with these advances, adds Savvides. Interestingly, the safety profile of immunotherapies completely differs from that of cytotoxic chemotherapy regimens that the field had been using. Immunotherapy appears to have a more favorable safety profile, concludes Savvides.

Related Videos
5 KOLs are featured in this peer exchange
5 KOLs are featured in this peer exchange
Jerôme Fayette, MD, PhD, medical oncologist, Centre Léon Bérard
Jun Gong, MD, associate professor, medicine, medical oncologist, Gastrointestinal Disease Research Group, Pancreatic Cancer Research Group, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai
Rebecca Klisovic, MD
Kedar Kirtane, MD, assistant member, Department of Head and Neck-Endocrine Oncology; medical director, Solid Tumor Cellular Therapy, Moffitt Cancer Center
Rohan Garje, MD
Cynthia Ma, MD, PhD
Arya Mariam Roy, MBBS
Karl Semaan, MD, MSc